导师简介

姓名: 薛慧如性别: 女政治面貌:中共党员
学历:博士学位:博士职称: 副主任医师
博、硕导师:硕导本岗位工作年数:18年
研究方向:神经免疫
荣誉称号:
山西省“三晋英才”支持计划青年优秀人才
英国牛津大学John Radcliffe Hospital访问学者
学术任职:
中国卒中学会免疫分会委员
山西省医学会神经病学专委会神经感染免疫学组副组长
山西省免疫学会神经免疫专委会秘书
山西省免疫学会神经感染免疫专委会常委
山西省老年医学学会老年神经医学委员会常委
山西省医师协会神经内科医师分会委员
山西省健康协会神经病学分会委员
近五年承担科研课题情况:
山西省科技厅青年自然研究基金,项目名称: 视神经脊髓炎昼夜节律紊乱特征及其机制的实验研究,项目编号:201901D211487
山西省科技厅面上自然研究基金,项目名称: 星形胶质细胞在视神经脊髓炎昼夜节律紊乱中的调控机制研究,编号:202403021221299
代表性论著及近五年的代表性论文(限10项以内):
1.Xue H, Wu M, Wang Y, Zhao Y, Zhang M, Zhang H. The circadian rhythms regulated by Cx43-signaling in the pathogenesis of Neuromyelitis Optica. Front Immunol. 2023 Jan 16;13:1021703. doi: 10.3389/fimmu.2022.1021703. PMID: 36726988; PMCID: PMC9885795.
2.Xue H, Yang W, Zhao Y, Wang L, Wang G, Zhang M, Zhang H. Pain in neuromyelitis optic spectrum disorder. Mult Scler Relat Disord. 2022 Dec;68:104192. doi: 10.1016/j.msard.2022.104192. Epub 2022 Sep 23. PMID: 36244188.
3.Xue H, Yang Z, Wang L, Jiang Y, Li J, Wu M, Wang G, Zhang Y, Zhang M. Factors Influencing the Degree of Disability in Patients With Multiple Sclerosis. Front Neurol. 2021 Oct 13;12:714631. doi: 10.3389/fneur.2021.714631. PMID: 34721257; PMCID: PMC8548829.
4.Xue H, Cao X, Zhang M. Alteration of Circadian Rhythms in 2D2 Transgenic Mice. Med Sci Monit. 2018 Nov 17;24:8272-8278. doi: 10.12659/MSM.908528. PMID: 30447063; PMCID: PMC6252048.
5.Wang M, Zeng P, Du C,Xue H, Cui Z, Zhang H, Jia D, Zhang C. Differential efficacy of mycophenolate mofetil in adults with relapsing myelin oligodendrocyte glycoprotein antibody-associated disorders. Mult Scler Relat Disord. 2021 Aug;53:103035. doi: 10.1016/j.msard.2021.103035. Epub 2021 May 24. PMID: 34077831.
6.Li H, Huang Z, Jia D,Xue H, Pan J, Zhang M, Shi K, Shi FD, Zhang C. Low-dose rituximab treatment for new-onset generalized myasthenia gravis. J Neuroimmunol. 2021 May 15;354:577528. doi: 10.1016/j.jneuroim.2021.577528. Epub 2021 Feb 24. PMID: 33662696.
7.Zhang M, Zhang C, Bai P,Xue H, Wang G. Effectiveness of low dose of rituximab compared with azathioprine in Chinese patients with neuromyelitis optica: an over 2-year follow-up study. Acta Neurol Belg. 2017 Sep;117(3):695-702. doi: 10.1007/s13760-017-0795-6. Epub 2017 Jun 12. PMID: 28608315.
8.Guo J, Wu J, Wang L, Liu H, Wu X, Yang H, Li W, Wang H, Bu B, Yang C, Zhou H, Guo S, Zhao Y, Wang Z, Li C, Tian DC, Chen S,Xue H, Zhang Y, Xu Y, Liang H, Wu Z, Zhang Y, Dong Q, Wang J, Quan C. Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China. Ther Adv Neurol Disord. 2024 Apr 13;17:17562864241239117. doi: 10.1177/17562864241239117. PMID: 38616782; PMCID: PMC11015775.
9.Li Y, Zhao R, Li L,Xue H, Meng H, Li G, Liang F, Zhang H, Ma J, Pang X, Wang J, Chang X, Guo J, Zhang W. Relative frequencies and clinical features of Guillain-BarréSyndrome before and during the COVID-19 pandemic in North China. BMC Infect Dis. 2024 May 30;24(1):541. doi: 10.1186/s12879-024-09401-1. PMID: 38816802; PMCID: PMC11138026.